Similares a AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD

19 vecinos (text_768) · 129 views · HCPLive · Estados Unidos


★	AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	129	Estados Unidos
4	A 'Holy Grail' Sleep Apnea Pill Could Be On The Market Next Year	Forbes @forbes	—	—	86
8	🔥 TESAMORELIN: Science-Backed rating from 1-10 🔬	Haad Mahmood, MD @haadmd	—	—	86
14	OSA (Obstructive Sleep Apnea) Comparison of Treatments	MedCram - Medical Lectures Explained CLEARLY @medcram	31.6K	Estados Unidos	85
19	You Might Not Actually Be Stupid, You Might Just Have Untreated Sleep Apnea	More Plates More Dates @moreplatesmoredates	20.5K	—	85
17	CagriSema: The Next Gen GLP1? #glp1 #news #healthandwellnessforseniors #semaglutide #wegovy	Dr. G's Lifestyle Medicine Network @gooddrg	3.2K	Estados Unidos	85
3	Inspire Implant for Sleep Apnea: What Your Actual Chance of Success Looks Like	CPAP Reviews @cpapreviews	2.5K	Australia	87
15	Prévention des récidives de MTEV : impact d’un traitement prolongé par apixaban dans l'étude HI-PRO	Cardio-online @cardio-online9873	581	Francia	85
11	GLP-1 Therapies: Where We’ve Been & Where We’re Going	Conversations on Health Care @cohcpodcast	541	Estados Unidos	85
12	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss	HCPLive @hcplivenews	250	Estados Unidos	85
20	Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes	HCPLive @hcplivenews	206	Estados Unidos	85
7	Rapid Evolution in GLP-1s and Therapeutics at ADA 2026	HCPLive @hcplivenews	171	Estados Unidos	86
1	What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	142	Estados Unidos	92
5	SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma	HCPLive @hcplivenews	78	Estados Unidos	86
18	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	85
6	ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	70	Estados Unidos	86
10	12.2025 Part 1: Battle to once weekly insulin approval – insulin efsitora alfa	aphapharmacists @aphapharmacists	70	—	86
2	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	88
9	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	86
16	Nuevos Fármacos para el Tratamiento de la Obesidad – Dr. Diego Schwarzstein – Clínica ServiDigest	Clínica ServiDigest @servidigest	41	—	85